Mobile DNA welcomes two new co-Editors-in-Chief

- 0 Comments

We are very pleased to announce that  Dr Henry Levin and Dr Cedric Feschotte have recently been appointed as co-Editors-in-Chief of Mobile DNA, working alongside Nancy Craig (Johns Hopkins University School of Medicine, USA) and Thomas Eickbush (University of Rochester, USA).

Dr Levin heads the Section on Eukaryotic Transposable Elements in the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, USA, which analyzes LTR retrotransposons as a model for the replication of retroviruses. Over the past 18 years Levin’s studies of LTR retrotransposons in fission yeast identified mechanistic details of particle formation, reverse transcription, and integration.

 

 

 

 

 

Dr Feschotte is an Associate Professor of Human Genetics at the University of Utah, USA. His lab focuses on mechanisms of transposition, the biological significance of endogenous viruses and host—virus evolution, and the contribution of mobile DNA to the advent of new biological functions and regulatory evolution.

 

 

 

We would also like to take this opportunity to thank Prof Daniel Voytas (University of Minnesota, USA) who has stepped down as co-Editor-in-Chief of Mobile DNA. His contribution to the journal since its inception is highly valued and we are pleased to have his ongoing support in his new role as an Editorial Board member for the journal.

Mobile DNA was launched in 2010 and publishes articles providing novel insights into DNA rearrangements in all organisms, ranging from transposition and other types of recombination mechanisms to patterns and processes of mobile element and host genome evolution. Thomson Reuters (ISI) recently confirmed that Mobile DNA is tracked for an impact factor (IF), and as such the journal should receive its first IF in June 2014. To sign up for Mobile DNA article alerts, submit a manuscript, or for more information about the journal, please visit the website or contact the Editorial Office.

 

We wish Dr Levin and Dr Feschotte all the best in their new roles!